These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 18413015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
    Tanna AP, Rademaker AW, Stewart WC, Feldman RM.
    Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM.
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medical therapy cost considerations for glaucoma.
    Fiscella RG, Green A, Patuszynski DH, Wilensky J.
    Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
    [Abstract] [Full Text] [Related]

  • 10. Primary drug treatment for glaucoma: beta-blockers versus other medications.
    Stamper RL, Wigginton SA, Higginbotham EJ.
    Surv Ophthalmol; 2002 Jul; 47(1):63-73. PubMed ID: 11801272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.
    Kobelt G, Jönsson L, Gerdtham U, Krieglstein GK.
    Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):811-21. PubMed ID: 9825256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost analysis of glaucoma medications.
    Vold SD, Wiggins DA, Jackimiec J.
    J Glaucoma; 2000 Apr; 9(2):150-3. PubMed ID: 10782624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Effect of Long-term Antiglaucomatous Drug Administration on Central Corneal Thickness.
    Schrems WA, Schrems-Hoesl LM, Mardin CY, Horn FK, Juenemann AG, Kruse FE, Braun JM, Laemmer R.
    J Glaucoma; 2016 Mar; 25(3):274-80. PubMed ID: 25383467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association between Glaucoma Medication Usage and Dry Eye in Taiwan.
    Chen HY, Lin CL, Tsai YY, Kao CH.
    Optom Vis Sci; 2015 Sep; 92(9):e227-32. PubMed ID: 26192153
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.